SCHEMBL2200641

SCHEMBL2200641

O=C(Nc1ccccc1Cl)C1CCCN1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.56
ROCK2 O75116 2/20 0.55
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
HDAC2 Q92769 3/20 0.49
HDAC3 O15379 2/20 0.49
HDAC4 P56524 2/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC9 Q9UKV0 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
POLB P06746 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TSHR P16473 1/20 0.49
TAS1R3 Q7RTX0 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200636 1.00 CYP2C19 (0.56) CYP2C19ROCK2NPC1RAB9AHDAC2
SCHEMBL1294945 0.85 HDAC2 (0.60) CYP2C19ROCK2HDAC2HDAC3HDAC4
SCHEMBL1294947 0.85 HDAC2 (0.60) CYP2C19ROCK2HDAC2HDAC3HDAC4
SCHEMBL18590935 0.84 ROCK2 (0.49) CYP2C19ROCK2HDAC2HDAC3HDAC4
SCHEMBL18572835 0.84 ROCK2 (0.49) CYP2C19ROCK2HDAC2HDAC3HDAC4
SCHEMBL7692266 0.84 HDAC2 (0.50) CYP2C19ROCK2NPC1RAB9AHDAC2
SCHEMBL7692271 0.84 HDAC2 (0.50) CYP2C19ROCK2NPC1RAB9AHDAC2
SCHEMBL29640018 0.83 ROCK2 (0.59) CYP2C19ROCK2NPC1RAB9AMEN1
SCHEMBL12649141 0.82 HDAC2 (0.52) ROCK2NPC1RAB9AHDAC2HDAC3
SCHEMBL10326402 0.82 SCN4A (0.51) ROCK2NPC1RAB9AHDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977343-B2 Adenine derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-07-12 US disclosed
US-20100160352-A1 ADENINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160352-A1 ADENINE DERIVATIVES HSP90AA1, TRAP1, HSP90AB1 CYP2C19 1847/4885ROCK2 2611/4885NPC1 1183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.